BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Sirenas

Sirenas logo

Website
http://sirenasmd.com/
Founded
2011
Patents
7
Publications
5

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

We bring unparalleled chemical diversity to areas of highest unmet medical need with the team and tools to turn the resulting discoveries into viable, high-impact therapeutics.
Over the last three years, our platform has been validated by pharma partners, helping them increase the chemical diversity of their therapeutic leads, including in cancer and antibiotics. We are now focusing on the discovery and development of novel and differentiated payloads for oncology antibody drug conjugates (ADCs) and have payload programs in various stages of optimization and preclinical development.

Antibody Drug Conjugates


Posts Mentioning This Company

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space

March 15, 2018  
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a notable amount of activity over the last several years with a considerable number of initiated research collaborations between AI-driven R&D vendors and top …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

ATLANTIS™, uses data mining and machine learning approaches to uncover the therapeutic potential of nature’s chemistry from a diversity of global microbiome collections. It provides rapid insights into the therapeutic potential, chemical novelty, structure activity relationships and global distribution of each metabolite.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.